Extract from the Register of European Patents

Citations: EP1931689

Cited inSearch
Type:Patent literature
Publication No.:US5753706  [XD]
 (HSU CHEN HSING [US]) [XD] 1-3,5-11,13-15 * column 9, lines 53-56 * * column 2, lines 54-65 * * column 1, paragraph 1 *
Cited inInternational search
Type:Patent literature
Publication No.:US5753706  [X]
 ;
Type:Patent literature
Publication No.:US6903235  [X]
Cited inExamination
Type:Non-patent literature
Publication information:   - HSU C H ET AL, "New phosphate binding agents: Ferric compounds", JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 199906 US, (199906), vol. 10, no. 6, ISSN 1046-6673, pages 1274 - 1280
Type:Non-patent literature
Publication information:   - WADA SHIN-ICHIRO ET AL, "Formation and properties of hydroxy iron(III) oligomer-citrate complex", SOIL SCIENCE AND PLANT NUTRITION, (199909), vol. 45, no. 3, ISSN 0038-0768, pages 725 - 728
Cited inOpposition
Type:Patent literature
Publication No.:US2006020026  
 * ) *
Type:Non-patent literature
Publication information:   - "Keryx announces positive final results from Phase 2 dose-ranging study of Zerenex? for the treatment of hyperphos- phatemia in patients with end-stage renal disease", Keryx Press Release, (20060629), XP055377101
Type:Non-patent literature
Publication information:   - YANG et al., "An open-label, crossover study of a new phosphate-binding agent in haemodialysis patients: ferric citrate", Nephrol. Dial. Transplant., (20020000), vol. 17, pages 265 - 270, XP055023585